Abstract:Background Microarray and microdissection techniques were being used for many applications to study the carcinogenesis of some human tumors. But seldom studies had hitherto combined these two techniques to study carcinogenesis mechanism of nasopharyngeal carcinoma (NPC). To identify a set of genes involved in the carcinogenesis and development of NPC, we used the microdissected homogeneous NPC tissue cells and the pure normal epithelium pillar cells to construct the whole human genome expression profiles. Methods We preserved the tissue samples from nasopharynx of 18 patients (including 13 samples of NPC and 5 samples of normal or inflammatory mucous tissue samples from nasopharynx) in RNAIater Stabilization Reagent. The tissue samples were microdissected to harvest the homogeneous tissue cells, then total RNA was isolated from them. The sufficient antisense RNA (aRNA) was amplified from these total RNA. HG-U133.Plus.2.0 GeneChip was used to construct the human whole genome expression profiling of each sample. Differential patterns of expression of genes correlated with the carcinogenesis, classification and progression of NPC were identified with comparing the expression profiling data respectively in leave one out cross-validation analysis. Correlation between aRNA expression measured by the microarrays and semi-quantitative reverse transcription polymerase chain reaction (sqRT-PCR) were also ascertained, and found that hybridization results were validated in all of the 18 patients. Results Differential patterns of expression of 127 genes correlated with the carcinogenesis (A P value less than 0.001 with the 2-fold differentiated expression between case group and control group) of the NPC were filtered. The top most up-regulated and down-regulated 8 genes by the way of permutation test were also selected and listed in the paper. Expression of genes E2F6 and TSPAN-1 was identified using aRNA by sqRT-PCR and showed that there was significant difference between the average value of case groups and that of control group respectively (t=2.170, df=16, P=0.045 and t=-2.946, df=16, P=0.009). Conclusions We had identified some genes which could be the molecular marker during the carcinogenesis and the development of the NPC. The genes which selected from the different subgroups seemed to be implicated for the diagnosis,classification, and progression of NPC, and provided important insights into their underlying biology.

[Gene Expression Profiling in Nasopharyngeal Carcinoma Determined by High Density Cdna Microarray].

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Identification of Differentially Expressed Genes in Nasopharyngeal Carcinoma by Means of the Atlas Human Cancer Cdna Expression Array

Identification of Differentially Expressed Genes in Primary Cultured Nasopharyngeal Carcinoma Cells by Cdna Microarray

Gene Expression Profiling of Nasopharyngeal Carcinoma Reveals the Abnormally Regulated Wnt Signaling Pathway.

Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray

[Differentially Expressed Gene in Nasopharyngeal Carcinoma Cell Lines with Various Metastatic Potentialities].

Alteration of Gene Expression During Nasopharyngeal Carcinogenesis Revealed by Oligonucleotide Microarray after Microdissection of Tumor Tissue and Normal Epithelia from Nasopharynx

Screen human nasopharyngeal carcinoma related genes with gene expression profile

Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma

Screening the differential expression genes of nasopharyngeal carcinoma using GenMAPP

Gene Expression Profile Changes and Possible Molecular Subtypes in Differentiated-Type Nonkeratinizing Nasopharyngeal Carcinoma

Transcriptional Patterns, Biomarkers and Pathways Characterizing Nasopharyngeal Carcinoma of Southern China

Identification of Differentially Expressed MicroRNAs in Nasopharyngeal Carcinoma

Microrna Expression Profiling of Nasopharyngeal Carcinoma.

Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis

Primary analysis of nasopharyngeal carcinoma patient's peripheral blood whole-genome microarray

Gene expression profile of immune cells from patients with nasopharyngeal carcinoma of stage T3-4N0]

Identifying Cancer-Related Genes in Nasopharyngeal Carcinoma Cell Lines Using DNA and Mrna Expression Profiling Analyses.

Comprehensive analysis of gene expression and DNA methylation for human nasopharyngeal carcinoma

Cdna Representational Difference Analysis of Differentially Expressed Cdna Sequences in Human Nasopharyngeal Carcinoma.